ClinicalTrials.gg
CompletedNCT07783685Updated Aug 25, 2026

Biochemical Factors in Patients With and Without Bruxism

An observational study in Bruxism, sponsored by Ankara Yildirim Beyazıt University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Ankara Yildirim Beyazıt University · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

This observational case-control study aimed to compare biochemical factors related to calcium metabolism between adults with and without bruxism. Participants were classified into bruxism and control groups based on self-reported bruxism behaviors assessed using the BRUX Scale together with standardized clinical examination findings. Serum vitamin D, parathyroid hormone (PTH), calcium, albumin, and albumin-corrected calcium levels were evaluated and compared between the two groups. The study aimed to determine whether these biochemical parameters differ between individuals with and without bruxism and to provide further insight into their potential relationship with bruxism

02

Conditions studied

  • Bruxism

Browse trials for

Keywords

  • Bruxism
  • vitamin D
  • Parathyroid hormone
  • Calcium
  • Albumin
03

In context

Bruxism

151 studies on the registry are indexed under Bruxism; 39 are open to participants now.

This study's enrollment of 60 is below the median of 89 across 55 observational studies indexed under Bruxism.

Browse Bruxism studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 241 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consisted of adults evaluated at the Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ankara Yildirim Beyazit University. Eligible participants with suspected bruxism were assessed using self-reported bruxism behaviors and standardized clinical examination findings. Participants meeting the predefined criteria for bruxism constituted the bruxism group. Eligible participants without bruxism were selected as controls and matched to the bruxism group according to age and sex. Biochemical laboratory results available from the preceding 6 months were evaluated.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age 18 years or older. (ASA) physical status I or II. Availability of biochemical laboratory results, including serum vitamin D, parathyroid hormone (PTH), calcium, and albumin, obtained within the previous 6 months.

Agreement to participate in the study.

Exclusion criteria

Exclusion Criteria:

Use of medications affecting vitamin D metabolism. Severe malocclusion. Complete or partial edentulism. Active dental or periodontal pain. History of jaw trauma. History of orthognathic surgery. History of temporomandibular joint (TMJ) surgery. Congenital craniofacial anomalies. Psychiatric disorders. Systemic diseases affecting bone metabolism.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • Bruxism Group

    Participants who met the predefined criteria for bruxism based on self-reported bruxism behaviors assessed using the BRUX Scale and standardized clinical examination findings

  • Control Grup

    Participants who did not meet the predefined criteria for bruxism and were matched to the bruxism group according to age and sex.

06

What researchers measure

Primary outcomes

  1. Serum Vitamin D,calcium,albumin and PTH level

    Serum 25-hydroxyvitamin D \[25(OH)D\], calcium, PTH and albumin levels were obtained from available laboratory records and compared between participants with and without bruxism.

    Time frame: Within 6 months before study assessment

07

Study locations

1 site
  • Ankara Yıldırım Beyazıt University
    Ankara, 06790, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2023 to primary completion in Nov 2023, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2026
First posted
Aug 25, 2026
StartActual
May 1, 2023
Primary completionActual
Nov 1, 2023
CompletionActual
Feb 1, 2024
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07783685
Responsible party
Sponsor
First posted
Aug 25, 2026
Start date
May 1, 2023
Primary completion
Nov 1, 2023
Completion
Feb 1, 2024
Last update
Aug 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion